key: cord-0920101-zx615vaw
authors: Björkström, Niklas K.; Strunz, Benedikt; Ljunggren, Hans-Gustaf
title: Natural killer cells in antiviral immunity
date: 2021-06-11
journal: Nat Rev Immunol
DOI: 10.1038/s41577-021-00558-3
sha: cd020315e7545a6cedc1a9872a936ad662c326b7
doc_id: 920101
cord_uid: zx615vaw

Natural killer (NK) cells play an important role in innate immune responses to viral infections. Here, we review recent insights into the role of NK cells in viral infections, with particular emphasis on human studies. We first discuss NK cells in the context of acute viral infections, with flavivirus and influenza virus infections as examples. Questions related to activation of NK cells, homing to infected tissues and the role of tissue-resident NK cells in acute viral infections are also addressed. Next, we discuss NK cells in the context of chronic viral infections with hepatitis C virus and HIV-1. Also covered is the role of adaptive-like NK cell expansions as well as the appearance of CD56(−) NK cells in the course of chronic infection. Specific emphasis is then placed in viral infections in patients with primary immunodeficiencies affecting NK cells. Not least, studies in this area have revealed an important role for NK cells in controlling several herpesvirus infections. Finally, we address new data with respect to the activation of NK cells and NK cell function in humans infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) giving rise to coronavirus disease 2019 (COVID-19).

Almost 50 years ago, a small number of research groups started to observe unexpected spontaneous cytotoxic activities among lymphocytes. While these were at first considered to be merely annoying background phenom ena, subsequent studies led to the realization that a new subpopulation of lymphocytes was responsible for this activity 1 . The cells were termed 'natural killer (NK) cells' . Over the years, insights into the molecular specificity of NK cells in terms of target cell recognition [2] [3] [4] and into their role in controlling viral and intracellular bacterial infections and tumours, as well as insights into their abil ity to regulate other immune cells, have put NK cells at the forefront of modern immunology 5 . Today, they are used as therapeutic agents in the treatment of human malignant diseases 6 , and strategies for using them thera peutically against viral diseases, including coronavirus disease 2019 (COVID19), are currently being explored 7 .

NK cells are best characterized by their cytotoxic function and their ability to produce cytokines upon stimulation 5 . With respect to their cytotoxic potential, they target infected, transformed and stressed cells. In this way, they not only eliminate unwanted cells but also contribute to cellular homeostasis 8 . The conven tional known anatomical site of NK cell production is the bone marrow, where interactions with other cellular components, cytokines and soluble molecules support and drive NK cell development (reviewed in ref. 9 ) (Box 1). Most of the current knowledge of human NK cells has arisen from studies of NK cells in peripheral blood and secondary lymphoid organs. Recently, however, there has been increased interest in NK cells residing in specific tissues 10 (so called tissue resident NK cells) (Box 2).

In humans, mature NK cells are traditionally identified as CD3 − CD56 + lymphocytes. They were long thought to represent a homogeneous population of cells. However, in line with adaptive lymphocytes, we now know that NK cells undergo a well defined differentiation process involving distinct phenotypic and functional changes (Box 1).

NK cell function is regulated by a large number of germline encoded receptors 11, 12 . Upon viral infection, host cells may become susceptible to NK cell mediated recognition through a variety of mechanisms that may include upregulation of self encoded molecules induced by the infection and/or a concomitant cellular stress response that binds activating NK cell receptors such as natural cytotoxicity receptors (NKp30, NKp44 and NKp46) 13 , C type lectin like receptors (for example, NKG2D and NKp80) 14 and co activating receptors (for example, DNAM1 and CD2) 12 . In parallel, contri buting to increased target cell susceptibility is the often observed downregulation of MHC class I ligands for inhibitory receptors 15 . Importantly, NK cells can also eliminate virus infected cells via CD16 mediated antibody-dependent cellular cytotoxicity (ADCC) 16 . Finally, NK cell activity is modulated by cytokines, including, but not limited to, the activating cytokines IL2, IL12, IL15, IL18 and type I interferons, which can be produced by virally infected cells or activated antigen presenting cells 17 . Many of these cytokines, alone or in combina tion, promote NK cell survival, proliferation, cytotox icity and cytokine production, including interferon γ (IFNγ) production 18 . Through these mechanisms, NK cells are uniquely equipped to sense and quickly respond Antibody-dependent cellular cytotoxicity (ADCC) . A mechanism by which natural killer cells, via their fc receptor CD16, kill a target cell whose membrane-surface antigens have been bound by a specific antibody.

to viral infections 7 . In this respect, they often act in con cert with other host immune responses in mediating antiviral immunity.

Here, we review recently obtained knowledge with regard to human NK cells in antiviral immunity. We address NK cell responses to typical acute viral infec tions. In many situations, these trigger activation of circulating NK cells and their homing to affected tissues. In parallel, tissue resident NK cells may also become activated. With respect to chronic viral infec tions, NK cells contribute to viral control. We describe how such infections may lead to 'adaptations' in the NK cell repertoire, likely contributing to their maintenance of viral control but possibly also representing a conse quence of exhaustion in some cases. Impairment in NK cell mediated viral control is seen in patients with inborn deficiencies affecting NK cell development and/or function. Finally, we pay specific attention to the very recently developing knowledge with respect to vigorous NK cell activation in human severe acute respiratory syndrome coronavirus 2 (SARS CoV2) infection and COVID19.

NK cells respond vigorously to several acute viral infec tions, exemplified in the following subsections by acute infections with flavivirus and influenza virus (both RNA viruses). In many situations, this triggers activation of circulating NK cells and their homing to affected tis sues. In parallel, specific tissue resident NK cells may also become activated. Critical to all host responses to acute viral infections is the balance between possible acute antiviral mechanisms and responses contributing to tissue damage and immunopathology.

Flaviviruses, including dengue virus (DENV), West Nile virus, Japanese encephali tis virus, tick borne encephalitis virus, yellow fever virus and Zika virus, are major emerging human pathogens, affecting millions of individuals worldwide. Flaviviruses elicit haemorrhagic fever like syndromes and central nervous system associated diseases in infected hosts 19 . Effective vaccines exist for some of these viral infections. With a few exceptions, there is a lack of knowledge with respect to which host cells are infected by flaviviruses in humans and whether they are targets of NK cell mediated responses. Innate immune responses elicited by flaviviruses have been studied extensively in animal models, in particular DENV and Zika virus infections 20 . However, fewer studies have focused specifically on NK cells in these acute viral infections, with influenza virus infections being an exception, as reviewed in the next subsection. In humans, NK cell responses to acute flavi virus infection have been addressed in clinical studies, particularly in DENV infections 21, 22 . While clinical stud ies performed to date have differed in their set up, some common observations have been made with respect to NK cell responses in different flavivirus infections.

In several studies, both CD56 bright NK cells and, in some studies, subpopulations of less differentiated CD56 dim NK cells (Box 1) have been reported to respond vigorously to infection [22] [23] [24] [25] . Type I and type III interferons likely con tribute to the NK cell responses observed in several flavi virus infections, including yellow fever virus infection 23 . Responses occur irrespective of NK cell education, and no evidence of specific adaptive-like NK cell responses has been observed 22, 23 . Concomitant with the increase in NK cell activation, increased levels of various cytokines, including IL12, IL15, IL18, IFNγ and tumour necrosis factor (TNF), have been detected in flavivirus infected patients 22, 23, 25 . In DENV infections, increased IL18 levels in plasma and in induced skin blisters, as well as concomitant signalling downstream of IL18 receptor in NK cells, have suggested an IL18 dependent mech anism in driving the proliferative NK cell response 22 . This proliferation might occur via nuclear factor κB (NF κB), AKT, activating transcription factor 2 (ATF2) and forkhead box protein O3 (FOXO3) or indirectly via IL18 induced upregulation of CD98 and consequently amino acid induced activation of mechanistic target of rapamycin (mTOR) 22 . NK cell produced IFNγ, on the other hand, has in other studies been suggested to be important for control of DENV infection 26 . These and other related studies illustrate the dynamics and specif ics of the early NK cell response during prototype acute flavivirus infections in humans. How NK cells contribute to viral clearance in experimental and human flavivirus infections remains to be explored in further detail.

Influenza viruses cause yearly global epidemics, with up to a billion infections annually 27 . While vaccines limit their spread, they do not prevent all infections. Typically, the virus infects lung epithelial cells. Like the situation in many viral infections, including SARS CoV2 infection (discussed in more detail below), infection with influenza virus can lead to excessive inflammation and tissue dam age. Although NK cells are part of this response, their contribution to host defence against influenza A virus (IAV) is not fully understood. Upon IAV infection in mice, increased accumulation of NK cells is observed in the lungs 28 . While local proliferation of pulmonary

Natural killer (NK) cells undergo the final steps of their development in secondary lymphoid organs, resulting in mature CD56 bright CD16 -NK cells that enter the circulation 146 . CD56 bright NK cells are efficient in producing cytokines but have limited cytotoxicity. They can further differentiate into CD56 dim CD16 + NK cells, the NK cell population most dominant in peripheral blood. Compared with CD56 bright NK cells, peripheral blood CD56 dim NK cells are a highly diverse population of immune cells 93 that undergo a continuous IL-15-driven differentiation process during their lifespan 34 . This differentiation is associated with changes in cell-surface phenotype, including loss of expression of CD94, NKG2A and CD62L (also known as L-selectin), as well as induction of killer cell immunoglobulin-like receptor (KIR) and CD57 expression 34, 36, 147, 148 . On a functional level, less differentiated CD56 dim NK cells are more highly proliferative and more responsive to cytokine stimulation, whereas highly differentiated CD56 dim NK cells lose their proliferative capacity and instead become more specialized with regard to cellular cytotoxicity and antibody-dependent cellular cytotoxicity 34 . A parallel pathway of NK cell differentiation occurs in non-lymphoid peripheral tissues (reviewed in ref. 10 ) (Box 2). Here, it is instead the less differentiated CD56 bright NK cells that are thought to enter tissue parenchyma and, in response to the local microenvironment, likely differentiate into site-adapted cells 50 . Understanding NK cell differentiation, the factors driving it and the functional specialization of the discrete differentiation stages provides a framework for subsequently interpreting NK cell antiviral immunity.

The process involving acquisition of functional competence in natural killer (NK) cells, often mediated by interactions between inhibitory receptors and the corresponding ligands. NK cells may account for part of this response, most of the NK cell accumulation in the lungs and airways during IAV infection has been suggested to be due to NK cell recruitment that is partly dependent on CXC chemokine receptor 3 (CXCR3) and CC chemokine receptor 5 (CCR5), respectively 28 . Several NK cell natu ral cytotoxicity receptors have been implicated in func tional activation of NK cells following influenza virus infection by binding to influenza virus haemagglutinin 29 . However, the degree to which NK cells contribute (if at all) to influenza virus elimination in this context is less clear. In humans, peripheral blood CD56 bright and CD56 dim NK cells have been shown to be primed during acute IAV infection 30 . Furthermore, in peripheral blood, a small subset of CD16 − CD49a + CXCR3 + NK cells has been identified, with CD49a and CXCR3 potentially promoting homing to and tissue retention in the lungs during acute infection. At the primary site of infection, it is not fully clear how circulating and tissue resident NK cells contribute to possible antiviral immunity or to pathology, such as by killing bystander cells 30 . Finally, studies in humans and macaques have demon strated that cross reactive antibodies elicited during seasonal influenza virus infections facilitate NK cell mediated ADCC with regard to infected target cells 31, 32 . This ADCC mediated response has been correlated with reduced disease severity. In infections such as influenza virus infection, more research is clearly needed to better delineate and discriminate between possible protec tive antiviral responses and those leading to excessive inflammation and tissue damage.

The acute NK cell response to infection with flaviviruses, including tick borne encephalitis virus, DENV and yellow fever virus, as well as SARS CoV2 (discussed in detail below), is to a large degree confined to less differentiated CD56 bright and CD56 dim NK cells 22, 23, 25, 33 (Box 1). Since these cells are more responsive to cytokines such as IL12, IL15, IL18 and type I interferons, probably in part because of higher expression of receptors for these cytokines 22, 34, 35 , it is likely that early NK cell activation is cytokine driven and less reliant on receptor-ligand interactions ( fiG. 1) . This results in stronger downstream signalling via signal transducer and activator of transcription 1 (STAT1), STAT4 and the PI3K-AKT-mTOR pathways in less differentiated NK cells 22, 36, 37 , in which mTOR, via the IRE1α-XBP1-MYC axis, is crucial for NK cell proliferation following acute activation 38 . Cytokine sig nalling via JAK-STAT pathways in NK cells was recently comprehensively reviewed elsewhere 39 . For induction of early NK cell activation, type I interferon signalling via STAT1 and IL12 plus IL18 signalling via STAT4 result in strikingly different interactions with the NK cell epi genetic landscape 40 . More specifically, STAT1 and STAT4 can exhibit antagonistic functions on their downstream networks early after NK cell activation, including STAT4 actively suppressing STAT1 expression 40 . Furthermore, whereas STAT4 binding resulted in increased chro matin accessibility, STAT1 interacted more with pro moter regions 40 . Although more long lasting effects of these alterations in the chromatin landscape remain elusive, it is possible that remodelling via IL12 plus IL18 and STAT4 could have more permanent effects as STAT4 signalling is important for the generation of both adaptive like and cytokine induced memory like NK cells 41, 42 .

A recent study by Sciumè and colleagues looked into the molecular mechanism of early NK cell activa tion in response to cytokines 43 . Analysis was focused on regions surrounding genes highly induced on early NK cell activation and revealed de novo chromatin and enhancer remodelling mediated by STAT4. These de novo enhancers were further repurposed to be used not only by STATs but also by the lineage defining transcription factor T bet 43 . Thus, although T bet and other lineage defining transcription factors were once considered pioneers for determining the shape of the epigenetic landscape that signal regulated transcription factors act on, this instead suggests that in acute activa tion of NK cells STATs will remodel chromatin accessi bility and invite lineage defining transcription factors to participate in novel ways in the acute response.

Since many viruses have narrow tropisms, infections often originate at the site of entry before spreading locally and/or systemat ically. Alternatively, they may be selectively restricted to a specific organ due to tissue tropism (for example, the liver in the case of hepatitis virus infections). From considerable work in mouse experimental models, it is known that recruitment of circulating NK cells to the site of infection is important for the early inflamma tory response and viral containment [44] [45] [46] [47] . Chemokinechemokine receptor interactions are necessary for mouse NK cell homing to tissues early in infection, and certain combinations come into action depending on the affected organ [45] [46] [47] . In a similar way, circulating NK cells migrate into lymph nodes in a CXCR5 dependent manner in macaques and help to control simian immuno deficiency virus (SIV) infection 48 . In humans, however, there is a relative scarcity of studies assessing NK cell homing to tissues during acute viral infections because of the inherent challenges in performing such studies and lack of easy access to infected tissue samples.

Over the last decade, our knowledge of the presence, development, differentiation and function of natural killer (NK) cells residing in peripheral tissues has increased dramatically (reviewed in ref. 10 ). It is now clear that most human organs, both lymphoid and nonlymphoid, contain tissue-resident NK cells expressing canonical tissue-residency markers such as CD69, CD103 and CD49a, all of which are functionally involved in retaining the cells in tissues 50, [149] [150] [151] and have been shown to, de facto, associate with tissue residency in human solid organ transplantation studies 152, 153 . The ontogeny of tissue-resident NK cells remains elusive. However, since their phenotype is in many respects (except for uterine NK cells) similar to that of blood CD56 bright NK cells, it is possible that they originate from CD56 bright NK cells that get cues to enter tissue microenvironments 10 . Alternatively, dedicated precursors may exist that seed peripheral tissues 154 . With their phenotype more resembling less mature CD56 bright NK cells, tissue-resident NK cells are in general less cytotoxic but more efficient in producing cytokines such as interferon-γ. While many human peripheral tissues contain a sizeable population of tissue-resident NK cells, mouse peripheral tissues such as the liver, salivary glands and uterus are instead populated by NK1.1 + CD49a + DX5 − cells referred to as group 1 innate lymphoid cells (ILC1s). Yet, ILC1s likely represent the mouse counterpart of human tissue-resident NK cells 155 .

Signalling pathways involving Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) downstream of many cytokine receptors, including those for iL-2, iL-12, iL-15 and type i interferons, but not iL-18, important in natural killer cell activation, proliferation and survival.

NATURe ReVIeWS | Immunology 0123456789();:

Nevertheless, in acute DENV infection, responding peripheral blood NK cells show a distinct chemo kine receptor imprint, including high expression of the skin homing marker cutaneous lymphocyte antigen. Because of this, high numbers of NK cells are present in the skin of patients early after infection 22 . Similarly, skin challenge with varicella zoster virus antigens in previ ously vaccinated individuals led to rapid recruitment of NK cells to the site of challenge 49 . However, studies in humans are warranted where NK cell homing to tissues during acute infections can be studied.

Besides homing of NK cells to tissues in response to acute viral infections, we have in recent years learned that most peripheral organs contain tissue resident CD56 bright NK cells (in humans) and/or group 1 innate lymphoid cells (ILC1s) (in mice) in the steady state (reviewed in ref. 10 These cells are often strategically positioned at the site of viral infection in organs, such as the liver, female gen ital tract, salivary glands, kidneys and intestine, poised to respond rapidly 10, 50 . Indeed, in mouse models it has been shown that tissue resident ILC1s confer early host protection 51 . Their human counterpart is most likely tissue resident CD56 bright NK cells (hereafter referred to as tissue resident NK cells), given their functional similarities, enrichment in tissues and shared expres sion of tissue residency markers (Box 2). Since tissue resident NK cells resemble circulating CD56 bright NK cells, cytokine and chemokine production is presumably the main function exhibited by these cells in early stages of infection (fiG. 1) . Tissue resident NK cells can also respond with local proliferation in acute and chronic viral infection 52 . Tissue resident NK cells have also been shown to more directly influence the magnitude of T cell responses via expression of the inhibitory ligand PDL1, leading to viral persistence but more limited immuno pathology after lymphocytic choriomeningitis virus infection 52 . In humans, a similar regulation of anti viral T cell immunity has been shown for liverresident NK cells in chronic hepatitis B virus (HBV) infection 53 . However, compared with what has been reported for conventional NK cell responses to viral infections, much less is known regarding the role of tissueresident NK cell responses. In this regard, it is striking to note that antigen specific NK cell responses to vaccination and/or infection appear to be largely confined to tissue resident NK cells in both humans and mice 49,54-56 (Box 3). Future work should aim at disentangling the relative contributions of migrating and tissue resident NK cells in antiviral responses occurring in peripheral organs.

NK cells adapt to chronic viral infection in ways that are only partially understood. These adaptations likely benefit viral control over time. Impairment of the ability to handle chronic viral infections, such as herpesvirus infections, is exemplified by the not seldom lethal con sequences of severe inborn deficiencies affecting NK cell development and/or function.

(HCV) belongs to the family Flaviviridae, it only rarely causes acute symptomatic disease. Instead, HCV is successful in evading the initial immune response and establishing chronic infection. There is strong evidence suggesting that NK cells contribute to HCV infection outcome, as the combination of KIR2DL3 with homo zygosity for the killer cell immunoglobulin-like receptor (KIR) ligand gene HLA-C1 has been associated with sig nificantly elevated viral clearance 57 . Furthermore, certain NK cell phenotypes are linked to reduced acquisition of chronic infection in exposed individuals as well as to the outcome of acute HCV infection 58, 59 . Yet once the virus persists and the infection becomes chronic, the rate of spontaneous clearance is low. In this phase, the immune response against the virus is hampered at several levels. T cells from patients with chronic HCV infection display reduced proliferation and cytokine production 60 , along with upregulation of inhibitory receptors 61,62 , a combi nation of features referred to as 'exhaustion' . From the lymphocytic choriomeningitis virus infection model, it is known that NK cells can contribute to sustain ing the chronic infection by targeting activated CD4 + T cells, which in turn leads to CD8 + T cell exhaustion 63 , and that NK cell depletion promotes antiviral CD8 + T cell immunity 64 . A similar mechanism has also been described in chronic HBV infection, in which NK cells mediate depletion of HBV specific T cells 53 .

In chronic HCV infection, NK cells display an altered phenotype and functionality. Yet the impact of chronic infection on NK cells appears to be, at least in part, unique to each individual. In assessment of the expression of activating receptors, both elevated and reduced frequencies have been reported 59, 65, 66 . Along the same lines, also for NK cell degranulation both reduced levels 65, 67 and elevated levels 68, 69 have been reported. By contrast, a consistent effect of chronic HCV infection on NK cells appears to be reduced production of proinflammatory cytokines [68] [69] [70] . Thus, although the NK cell compartment is indeed affected in chronic HCV infection, certain aspects of this appear to rely on other factors, such as the duration of infec tion or the underlying state of liver disease. This effect of chronic HCV infection on the NK cell compartment is likely to be caused by a plethora of mechanisms, but it has been shown that the direct interaction of NK cells with HCV infected cells leads to reduced expres sion of NKG2D and decreased functionality 71 . In line with this, NS5A mediated production of transforming growth factor β could also be linked to reduction of NKG2D expression 67 . In recent years, the development of direct acting antivirals has revolutionized HCV infec tion therapy, as these drugs lead to successful viral clear ance in nearly all patients, with negligible side effects. This has also made it possible to assess the capacity for reinvigoration of NK cell function after rapid clearance of a chronic infection (Box 4).

Killer cell immunoglobulin-like receptor (Kir) . A family of highly polymorphic activating and inhibitory receptors that serve as key regulators of human natural killer cell function. Fig. 1 | nK cell differentiation as a framework to understand nK cell antiviral immunity. The differentiation status of human natural killer (NK) cells determines their functional response in viral infections. CD56 bright NK cells and less differentiated CD56 dim NK cells express high levels of NKG2A, natural cytotoxicity receptors (NCRs; NKp30, NKp44 and NKp46) and proinflammatory and antiviral cytokine receptors (IL-12 receptor (IL-12R), IL-18R and type I interferon receptor (IFNAR)). During acute viral infections, with ensuing production of IL-12, IL-18 and type I interferons by other immune cells, less differentiated NK cells are the main NK cell subset to respond. As indicated by black arrows, cytokine stimulation leads to signalling via signal transducer and activator of transcription 1 (STAT1) and STAT4 and PI3K-AKT-mTOR pathways to rapidly induce NK cell cytokine production and proliferation. With increased maturation, circulating CD56 bright NK cells undergo a phenotypic shift and their responsiveness during infection becomes altered. As a consequence, more differentiated NK cells are more prone to respond to cytomegalovirus, leading to the expansion of adaptive-like NK cells that express high levels of killer cell immunoglobulin-like receptors (KIRs) and NKG2C. Circulating CD56 bright NK cells might also home to tissues, giving rise to tissue-resident NK cells. Their role in the early response to infection remains elusive. However, liverresident NK cells have been shown to mediate antigen-specific antiviral responses. Alterations in transcription factor expression during NK cell differentiation are indicated within the respective cell nuclei, and a summary of phenotypic changes during NK cell differentiation is depicted in the table. For some receptors, the expression depends on the tissue microenvironment and specific subsets studied and will deviate from what is indicated here (denoted by the asterisk). CLA, cutaneous lymphocyte-associated antigen; HAV, hepatitis A virus; HBV, hepatitis B virus; ISG, interferon-stimulated gene; NA, not available. HIV-1 infection. The effector capacity of NK cells includes cytotoxic elimination of HIV1 infected tar get cells, as well as secretion of IFNγ, TNF and CCL4, influencing antiviral responses and limiting viral spread 72, 73 . Notably, however, a differential role for cytokines, including TNF and IFNγ, has been observed in chronic states of the infection 74, 75 . NK cells also pro duce β chemokines, CCL3, CCL4 and CCL5, which function as natural ligands of CCR5, hampering HIV infectivity of target cells 76 . Additionally, population level genetic associations between NK cell receptor expres sion and HIV1 infection outcome and evolution have clearly revealed the impact of NK cells on HIV1 dis ease progression. In HIV, KIR-HLA combinations have been associated with the pace of disease progression 77 and protection against disease acquisition 78 . In detail, HLA-B Bw4-80I in combination with KIR3DL1*h but also with KIR3DS1 could be linked to improved viral control 77, 79 . The mechanisms conferring this protection may include both NK cell education through inhib itory receptor ligation 80 and the direct interaction of KIRs with HIV1 derived peptide motifs presented on HLA molecules 81, 82 . Indeed, for KIR3DS1 + NK cells, an HLA-B Bw4-80I dependent suppression of viral rep lication has been shown 83 , further supporting a direct role for NK cells in mediating the observed protec tive effect. HIV1 mediated downregulation of HLA molecules, which prevents infected cells from lysis by CD8 + T cells 84 , may also facilitate NK cell recognition of infected cells. However, this is limited by preservation of expression of HLA C and HLA-e 85 . HIV1 infection has also been shown to trigger the upregulation of ligands for NKG2D and other activating receptors 86 . However, HIV1 has enabled mechanisms to limit the recognition of these ligands through the expression of viral acces sory proteins 87, 88 . Furthermore, responses characterized by coordinated antibody function, including NK cell mediated ADCC, are associated with viral controller phenotypes 89 .

Like for many other viral infections, changes in NK cell receptor repertoire and functionality are observed during HIV1 infection. For example, treatment naive HIV1 infected individuals have a significant loss of CCR7 + CD56 bright NK cells, and this change has been associated with higher viral loads 90 . Loss of the CD56 dim NK cell subset during HIV1 infection has also been observed 90 . Animal models of SIV infection have shown accumulation of CD56 − CD16 + NK cells in lymph nodes 91 . Since HIV1 infection is often subjected to pharmacological intervention, the effects of therapies on NK cells have been studied. Initiation of antiretro viral therapy has been associated with alterations in the CD56 bright and CD56 dim NK cell populations, with the former increasing after therapy 92 . 94 . Some of these changes are evident as the appearance of adaptive like NK cell expansions (reviewed in ref. 95 ) that have been extensively studied in the mouse cyto megalovirus (MCMV) infection model 96 . In this infec tion, Ly49H + NK cells that specifically recognized the MCMV encoded glycoprotein m157 were expanded on primary infection 96 . These NK cells were shown to confer protection against MCMV following rechallenge with the virus 97 . Adaptive like NK cell expansions have also been identified in humans. The very first indica tions of adaptive like NK cells came from observations on the expansion and persistence of CD94 + NKG2C + NK cells in humans infected with human cytomegalo virus (HCMV) 98 . Adaptive like NK cell expansions have also been observed following diverse viral infections in humans, including hantavirus infection 99 , chikungunya virus infection 100 and HIV1 infection 101 . Notably, all these responses correlated with HCMV co infection, suggesting that subclinical reactivation of HCMV could be one mechanism underlying the observed responses. By contrast, several other infections, including recurrent herpes simplex virus 2 infection 102 and acute Epstein-Barr virus (EBV) infection 103 , have not been associated with an expansion of NKG2C + NK cells. Furthermore, adaptive like NK cell expansions observed in individu als infected with HBV, HCV and/or hepatitis delta virus were shown not to be linked to the chronic hepatitis infections per se but rather to be consequences of an underlying HCMV infection 104 . Distinct from adaptive like NK cell expansions characterized by a reshaping of the NK cell repertoire towards certain subpopulations, additional animal models of herpes simplex virus, influenza virus and SIV infection and more recently also work in the human setting assessing vaccination responses have revealed the existence of antigen specific NK cell responses (Box 3).

In more in depth recent work in humans, several characteristics of adaptive like NK cells have been iden tified, including clonal expansion, persistence and recall responses 105, 106 . Furthermore, these cells are characterized by low expression of the transcription factor zinc finger protein PLZF (also known as ZBTB16), silencing of HLA-E Non-classical MHC class i molecule characterized by a limited polymorphism that normally binds a restricted subset of peptides derived from signal peptides.

More than a decade ago, we learned of antigen-specific responses mediated by mouse natural killer (NK) cells 54, 55, 97 . These involved antigen-specific recall responses to haptens but also responses against viruses after prior sensitization. Intriguingly, the responses were largely confined to CXC-chemokine receptor 6 (CXCR6)-positive liver-resident NK cells 54, 55 . Similarly, hepatic, but also splenic, NK cells from macaques infected with simian-human immunodeficiency virus and simian immunodeficiency virus or adenovirus vector-vaccinated animals demonstrated long-term antigen specificity in an NKG2dependent manner 156 . Recently, such NK cell phenomena have also been reported in the human setting. First, Nikzad and colleagues showed that human NK cells, in humanized mice, exhibited vaccination-dependent, antigen-specific recall responses upon secondary challenge in vitro 49 . Interestingly, in line with findings from mouse and macaque models, these responses were also confined to hepatic CXCR6 + NK cells 49 . The human liver is enriched in NK cells and contains a sizeable tissue-resident NK cell subpopulation 149 . Given this and the association between liver NK cells and antigen-specific NK cell responses from experimental models, it was no surprise that two studies in 2020 reported human liver NK cell antigen-specific responses against hepatitis A virus and hepatitis B virus following vaccination against these viruses 56, 157 . The CD49a + CD16 − hepatic NK cells mediating these antigen-specific responses had a primed epigenetic state compared with conventional CD49a − CD16 + NK cells, yielding hyper-responsiveness upon IL-2 plus IL-15 stimulation 56 . However, the mechanism for antigen specificity currently remains elusive and so does the broad usefulness of these cells against other future infections.

www.nature.com/nri 0123456789();: intracellular signalling molecules and commonly also expression of CD57 (refS 107, 108 ). Human adaptive like NK cell expansion depends on expression of the NKG2C ligand HLA E 109 . Adaptive like NKG2C + NK cells dif ferentially recognize distinct HCMV strains encoding variable UL40 peptides that, in combination with proin flammatory signals, control expansion and differentia tion of adaptive like NKG2C + NK cells 110 . Interestingly, HCMV seropositive individuals possessing a homozygous null allele of KLRC2 (encoding NKG2C) remain healthy. In these individuals, the adaptive like NK cell expan sions instead expressed elevated levels of CD2, which synergized with CD16 to activate NK cells in HCMV infection 111 . It is not unlikely that there are additional environmental factors that similarly shape NK cell pheno type and function that are even less well understood. Finally, since adaptive like NK cell expansions decrease NK cell repertoire diversity, the long term consequences of this for the individual remain elusive.

A particular hall mark of chronic viral infections such as HIV1 and HCV infections is the expansion of a subset of CD56 − NK cells (reviewed in ref. 112 ). More recently, CD56 − NK cells have also been observed to be expanded in HCMV seropositive and EBV seropositive elderly individuals 113 . In healthy individuals, the CD56 − NK cell subset encom passes only a small proportion of the NK cell com partment in peripheral blood 114 . In chronic infections, however, it may constitute up to half of all peripheral NK cells, largely at the expense of the CD56 dim NK cell subset [115] [116] [117] . The CD56 − NK cell population displays an exhausted phenotype, with reduced levels of perforin, granzyme B, IFNγ and TNF, and lower cellular cytotox icity than CD56 dim NK cells 117, 118 . It has remained unclear to what extent these expanded CD56 − NK cells represent a similar or distinct phenotype as compared with the CD56 bright or CD56 dim NK cell populations in healthy individuals. However, more recently, an unbiased sur face receptor screen and a global proteome analysis were performed to obtain detailed molecular and phenotypic information of the CD56 − NK cell subset 119 . It was revealed that CD56 − NK cells have a surface proteome and a total proteome related to, but not identical to, those of CD56 dim NK cells. Functional investigations in that study examining degranulation, cytotoxicity and IFNγ production of CD56 − NK cells from healthy individuals largely confirmed an, at most, moderate responsiveness of these cells 119 .

Studies of patients with more than 400 different primary immunodeficiency diseases (PIDs) have provided key insights into host control of viral infections. NK cells are affected in more than 50 PIDs. At present, at least seven PIDs have an abnormality specifically affecting NK cells (reviewed in ref. 120 ) (fiG. 2) . These specific NK cell deficiency disorders include mutations affecting total NK cell numbers, NK cell subsets and/or NK cell functions 120 . The genes affected in these seven NK cell deficiencies are GATA2 (ref. 121 126 ) and FCGR3A 127 . The first six genes affect NK cell development or maturation, with resulting low total NK cell numbers and specific defects affecting NK cell subsets. FCGR3A gene mutations affect NK cell func tion despite normal numbers of NK cells 120 . This is due to a homozygous mutation in FCGR3A (which encodes CD16) 127, 128 . Intriguingly, despite CD16 functioning as an IgG Fc receptor, patients with mutations in FCGR3A have impaired natural cytotoxicity but intact ADCC function 128 . The clinical presentation of human NK cell deficiency varies from patient to patient; however, hall mark viral infections affecting these individuals include herpesvirus infections such as HCMV, EBV, herpes simplex virus and varicella zoster virus infections 120,126 (fiG. 2) . These viruses cause disease in almost 60% of reported NK cell deficiency cases 120 . On the basis of these findings, one may argue that host defence against her pesvirus infections might be one of the most important functions of NK cells in the context of antiviral immu nity. In addition, some other viral infections have been reported in patients with NK cell deficiency, including human papillomavirus infection and some respiratory infections 120 . Interestingly, these observations suggest an important role for NK cells in keeping these, often latent, infections under control. Notably, of patients with reported NK cell deficiency, almost half have been reported to have died prematurely 120 , underscoring the severity of these diseases. Corroborating these find ings, in studies of patients with a GATA2 deficiency, the frequencies of NK cells were directly associated with increasing complications of disease 129 .

In late 2019, a new zoonotic viral pathogen, SARS CoV2, emerged and rapidly spread throughout the world, caus ing more than 60 million infections and 1.5 million deaths during the first year of the pandemic 130 . SARSCoV2

Since chronic viral infections are cleared only very rarely, it is seldom possible to study immune system reinvigoration after removal of the chronic insult. For instance, antiviral treatment of HIV-1 infection can successfully suppress viral replication but not permanently remove the virus and/or infection. In this regard, the introduction of treatment with direct-acting antivirals for hepatitis C virus (HCV) has presented a unique opportunity for immunologists to address immune system restoration upon pathogen removal. While the viral loads of HCV drop rapidly upon treatment, immune functions appear to be restored only partially. For example, the proliferative capacity of HCV-specific CD8 + T cells is restored 158 but mitochondrial alterations persist over time 159 . Along the same lines, the levels of many, but not all, soluble inflammatory serum proteins that are altered in chronic HCV are normalized upon viral clearance 160 . Furthermore, the unconventional mucosa-associated invariant T cell subset exhibits phenotypic and functional alterations long after viral clearance 161 . For natural killer (NK) cells, partial reinvigoration upon viral clearance has been described, although certain NK cell features appear to be affected for a prolonged period. In more detail, a reversal of NK cell activation 69 and a rapid restoration of signal transducer and activator of transcription 1 (STAT1) expression and associated type I interferon responsiveness have been described 162 . On the other hand, the diversity of the NK cell population appears not to be restored after viral clearance 163 . This might be explained by epigenetic changes caused by chronic infection that are long-lasting in nature. Indeed, in human cytomegalovirus infection, it has been shown that adaptive-like NK cell expansions display epigenetic modifications 108 and that chronic antigen stimulation is a driver for such modifications and for related functional alterations 164 . It is thus plausible that such epigenetic modifications also occur in the context of chronic HCV infection. NATURe ReVIeWS | Immunology 0123456789();: infection can cause COVID19, a respiratory and vas cular disease which, in severe cases, can lead to acute respiratory distress syndrome, multi organ failure and death 130, 131 . Although the disease pathogenesis is not yet completely understood, a misdirected and hyperacti vated immune system is thought to contribute to severe COVID19, with a likely contribution from NK cells.

NK cell response to SARS-CoV-2. NK cells are early responders to acute SARS CoV2 infection, with recruit ment of CD56 bright and CD56 dim NK cells from the cir culation to the lungs, leading to reduced numbers of circulating NK cells in acute infection 33, [132] [133] [134] [135] (fiG. 3) . A gene module for chemotaxis is induced in lung NK cells 33, 135 , and lungs of patients with COVID19 contain elevated levels of chemokines such as CCL3, CCL3L1, CCL4, CXCL9, CXCL10 and CXCL11 (refS 135, 136 ). Although further work is needed in the area, this chemokine production suggests that CXCR3 and CCR5 are important for homing of NK cells to the lungs in acute SARS CoV2 infection 137 . The early depletion of NK cells from the circulation and their redistribution to the site of infection is in line with what has been observed in other severe acute infections, such as acute hantavirus infection 99 . Furthermore, NK cells display an activated and cycling phenotype in acute SARS CoV2 infection at both the protein level and the transcriptomic level, with upregulation of Ki67, CD69, HLA DR and CD38 (refS 33, 132, 134 ). In the CD56 dim NK cell compart ment, less differentiated NKG2A + CD62L + CD57 − KIR − cells were the main responding cells, suggesting a cytokine driven mechanism of activation 33 (Box 1;  fiG. 1 ). Paralleling the activation of NK cells, regulatory programmes appear to be initiated, as evidenced by the upregulation of inhibitory checkpoint receptors such as LAG3, TIGIT and TIM3 (refS 33,132 ) (fiG. 3) . This could possibly explain why peripheral blood NK cell function has been reported to be blunted in acute SARS CoV2 infection 133, 138 .

Although NK cells appear to be robustly activated and home to the lungs in acute SARS CoV2 infection, from the currently available studies, the level of NK cell activation (induction of CD69 and HLA DR expression) or proliferation is not associated strongly with COVID19 severity. Instead, Maucourant and colleagues reported that severe/critical COVID19 was associated with the appearance of adaptive like NK cell expansions 33 (fiG. 3) . These expan sions where characterized by high NKG2C and CD57 expression as well as by narrow KIR profiles 33 . Since the first report, similar findings have been reported in two additional studies 133, 139 . It currently remains unclear whether the increased frequency of adaptive like NK cells in severe COVID19 is because of a direct effect of SARS CoV2 or whether this is a bystander phenom enon driven by HCMV 33 . Indeed, a history of HCMV infection appears more common in patients with severe COVID19 (ref. 140 ), and some evidence of local HCMV reactivation in the lungs of patients with COVID19 receiving ventilator treatment has been reported 141 . On the other hand, both immune and parenchymal cells in the lungs of patients with COVID19 display elevated HLA E expression 33 , and it has been suggested that the SARS CoV2 spike protein can induce surface HLA E expression by lung epithelial cells 142 . However, it remains to be determined whether upregulated HLA E will stimulate NK cells via NKG2C or rather inhibit the NKG2A expressing NK cells.

Future research should also address whether expan sion of adaptive like NK cells is needed to unleash the full antiviral capacity of NK cells against SARS CoV2 infec tion or whether these cells are instead contributing to COVID19 pathogenesis. In this regard, it is interesting to note that a recent artificial intelligence guided big data approach identified a 'severe viral pandemic core gene signature' that highlighted IL15-IL15RA and NK cell senescence as important determinants for severe or fatal COVID19 (ref. 143 ). Corroborating this, it was recently suggested that IL15 could be linked to NK cell dysfunc tion in COVID19 and that this occurs late after symp tom onset and only in the most severely ill patients 144 . Thus, these studies support a model in which misdirected and/or exhausted NK cell responses, rather than hyperac tivated NK cells, contribute to severe COVID19. Future work should explore the contribution of myeloid derived suppressor cells and immature neutrophils 145 in relation to NK cell dysfunction in severe COVID19 (fiG. 3) .

As is evident from studies reviewed herein, it is clear that NK cells can mount vigorous responses to several acute viral infections, including acute flavivirus and influenza virus infections as discussed here. In many situations, this triggers homing of circulating NK cells to affected tissues. In parallel, less well characterized tissue resident NK cells may also become activated. Critical in all host responses to acute viral infections is the balance between acute anti viral mechanisms and responses contributing to tissue damage and immunopathology. Clearly, more knowledge is needed with respect to direct NK cell mediated inter actions with viral infected cells and the consequences of possible viral clearance by such interactions. NK cells adapt to chronic viral infections in ways that are only par tially understood. These adaptations likely benefit viral control over time, although the detailed mechanisms are far from completely understood. Impairment of the abil ity to handle chronic viral infections, such as herpesvirus infections, is exemplified by the lethal consequences of severe inborn deficiencies affecting NK cell development and/or function. As discussed, at least seven PIDs have an abnormality specifically affecting NK cells. With the recent COVID19 pandemic, NK cells have come into the spotlight in this context as well. Although the dis ease pathogenesis is still being worked out, a misdirected and hyperactivated immune system is thought to con tribute to severe COVID19, with a likely significant contribution from NK cells (fiG. 3) . While many insights with respect to a possible role for NK cells in viral infections have been revealed, from studies in mouse models to studies in humans, there are several outstanding questions and unre solved issues. What is the nature of NK cell viral anti gen specificity as observed in, for example, hepatitis A virus and HBV vaccination (Box 3)? Furthermore, regarding antigen specific NK cell responses, what are specific surface receptor mediated responses ver sus what might be novel forms of antigen specificity 'dictated' by changes at an epigenetic level (Box 3)? On the same note, what drives adaptive like expansions of NK cell populations? What is the function of these cells in the context of viral infection? How are NK cells driven towards sites of infection and what is the role of responses from tissue resident NK cells in the context of acute infections? Is there a division of labour between infiltrating NK cells and tissue resident NK cells? What distinguishes functional antiviral NK cell responses from disease causing responses? This is a question of relevance with regard to both acute responses, like in the SARS CoV2 situation (fiG. 3) , and chronic infec tions, such as HIV1 and HCV infections. With regard to vaccination, a presently hot topic, what is the role of NK cells in the generation of efficient vaccine responses? Finally, while this has been discussed for years, is there a role for NK cells in settings of adoptive immunotherapy for viral diseases such as what we are currently witnessing in the context of human malignant diseases?

In summary, although we have gained a great deal of knowledge of NK cells in the context of human viral infections over the past 10 years, much more remains to be learned.

Published online xx xx xxxx

Natural' killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy

In search of the 'missing self': MHC molecules and NK cell recognition

Natural killer cells: from no receptors to too many

Functions of natural killer cells

Exploring the NK cell platform for cancer immunotherapy

Flattening the COVID-19 curve with natural killer cell based immunotherapies

NK cell development and function-plasticity and redundancy unleashed

NK cell development, homeostasis and function: parallels with CD8 + T cells

Emerging insights into natural killer cells in human peripheral tissues

NK cell recognition

Activation, coactivation, and costimulation of resting human natural killer cells

Human natural killer cell receptors and co-receptors

Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex

Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets -but how many arrows in the quiver?

Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells

Developmental and functional control of natural killer cells by cytokines

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

Viral innate immune evasion and the pathogenesis of emerging RNA virus infections

Defining the role of NK cells during dengue virus infection

NK cells are activated and primed for skin-homing during acute dengue virus infection in humans

A detailed assessment of the NK cell response including tissue homing in acute DENV infection

The human NK cell response to yellow fever virus 17D is primarily governed by NK cell differentiation independently of NK cell education

The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection

NK cell responses to human tick-borne encephalitis virus infection

Dengue virus-infected dendritic cells, but not monocytes, activate natural killer cells through a contact-dependent mechanism involving adhesion molecules

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

Natural killer cell recruitment to the lung during influenza a virus infection is dependent on CXCR3, CCR5, and virus exposure dose

Influenza a virus hemagglutinin and other pathogen glycoprotein interactions with nk cell natural cytotoxicity receptors NKp46, NKp44, and NKp30

Influenza a virus infection induces hyperresponsiveness in human lung tissueresident and peripheral blood NK cells

Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses

Natural killer cell immunotypes related to COVID-19 disease severity

The first report on the NK cell response in COVID-19

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education

An article outlining a stepwise programme for human NK cell differentiation

Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals

CD94 surface density identifies a functional intermediary between the CD56 bright and CD56 dim human NK-cell subsets

CD56 bright NK cells exhibit potent antitumor responses following IL-15 priming

The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc

JAK/STAT cytokine signaling at the crossroad of NK cell development and maturation

Epigenetic control of innate and adaptive immune memory

Cutting edge: stage-specific requirement of IL-18 for antiviral NK cell expansion

Cytokine activation induces human memory-like NK cells

Rapid enhancer remodeling and transcription factor repurposing enable high magnitude gene induction upon acute activation of NK cells

Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways

CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells

Susceptibility of CCR5-deficient mice to genital herpes simplex virus www

to NK cell mobilization

Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1

Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys

A study showing the importance of NK cell migration to tissues in control of viral infection in non-human primates

Human natural killer cells mediate adaptive immunity to viral antigens

The first article showing antigen-specific NK cell responses in humanized mice

Tissue determinants of human NK cell development, function, and residence

ILC1 confer early host protection at initial sites of viral infection

Liver-resident NK cells control antiviral activity of hepatic T cells via the PD-1-PD-L1 axis

Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion

T cell-and B cell-independent adaptive immunity mediated by natural killer cells

Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses

A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses

The first study reporting on antigen-specific NK cell responses in humans

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro

Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance

Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection

PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients

Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation

Natural killer cells act as rheostats modulating antiviral T cells

Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C

Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients

Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines

Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections

Successful interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function

Compromised function of natural killer cells in acute and chronic viral hepatitis

Cell-tocell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells

NK cells in HIV disease

NK cells in HIV-1 infection: from basic science to vaccine strategies

Use of tumor necrosis factor (TNF) inhibitors in patients with HIV/AIDS

The significance of Interferon-γ in HIV-1 pathogenesis, therapy, and prophylaxis

Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1

Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

Controlling natural killer cell responses: integration of signals for activation and inhibition

HIV-1 adaptation to NK-cell-mediated immune pressure

Selection of an HLA-C*03:04-restricted HIV-1 p24 Gag sequence variant is associated with viral escape from KIR2DL3+natural killer cells: data from an observational cohort in South Africa

Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

Selective downmodulation of HLA-A and -B by Nef alleles from different groups of primate lentiviruses

HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing

The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells

Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu

Polyfunctional HIV-specific antibody responses are associated with spontaneous HIV control

Loss of CCR7 expression on CD56 bright NK cells is associated with a CD56 dim CD16 + NK cell-like phenotype and correlates with HIV viral load

Accumulation of cytotoxic CD16+ NK cells in simian immunodeficiency virus-infected lymph nodes associated with in situ differentiation and functional anergy

Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial

Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry

Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility

Clonal expansion of innate and adaptive lymphocytes

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

Adaptive immune features of natural killer cells

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts

Rapid expansion and longterm persistence of elevated NK cell numbers in humans infected with hantavirus

Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity

Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients

Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection

Cutting edge: NKG2C hi CD57 + NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus

Cytomegalovirus-driven adaptive-like natural killer cell expansions are unaffected by concurrent chronic hepatitis virus infections

Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells

ARID5B regulates metabolic programming in human adaptive NK cells

Epigenetic modification and antibodydependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function

the first work showing epigenetic modifications of adaptive-like NK cells

IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells

Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans

CD56 negative NK cells: origin, function, and role in chronic viral disease

CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals

Elevated natural killer cell activity despite altered functional and phenotypic profile in Ugandans with HIV-1 clade A or clade D infection

Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates

Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection

Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment

Proteome analysis of human CD56 neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56 dim NK cells

Emerging insights into human health and NK cell biology from the study of NK cell deficiencies

The first article reporting on an individual with a complete NK cell deficiency

Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency

A homozygous mutation of RTEL1 in a child presenting with an apparently isolated natural killer cell deficiency

Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency

Biallelic mutations in IRF8 impair human NK cell maturation and function

Human NK cell deficiency as a result of biallelic mutations in MCM10

Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity

Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections

GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity

Clinical characteristics of coronavirus disease 2019 in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Unique immunological profile in patients with COVID-19

The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis

Distinct lung-homing receptor expression and activation profiles on NK cell and T cell subsets in COVID-19 and influenza

Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19

Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression

Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients

SARS-CoV-2 spike 1 protein controls natural killer cell activation via the HLA-E/NKG2A pathway

AI-guided discovery of the invariant host response to viral pandemics

Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19

Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity

A human CD34 + subset resides in lymph nodes and differentiates into CD56 bright natural killer cells

CD62L expression identifies a unique subset of polyfunctional CD56 dim NK cells

CD57 defines a functionally distinct population of mature NK cells in the human CD56 dim CD16 + NK-cell subset

Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells

Unique transcriptional and protein-expression signature in human lung tissue-resident NK cells

Composition and dynamics of the uterine NK cell KIR repertoire in menstrual blood

Generation and persistence of human tissue-resident memory T cells in lung transplantation

Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome

Systemic human ILC precursors provide a substrate for tissue ILC differentiation

Natural killers or ILC1s? That is the question

A study showing the presence of antigen-specific NK cell responses in non-human primates

HBV vaccination and HBV infection induces HBV-specific natural killer cell memory

Restoration of HCV-specific CD8+ T cell function by interferon-free therapy

Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses

Direct-acting antiviral-induced hepatitis C virus clearance does not completely restore the altered cytokine and chemokine milieu in patients with chronic hepatitis C

Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy

Rapid decrease in hepatitis C viremia by direct acting antivirals improves the natural killer cell response to IFNα

Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity

Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming

The authors thank present and past members of their groups for their contributions towards the understanding of human natural killer cells in health and disease. Their work was supported by the Swedish Research Council, Sweden's Innovation Agency, the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 948692), the Swedish Cancer Society, the Swedish Foundation for Strategic Research, the Knut and Alice Wallenberg Foundation, Nordstjernan AB, the Center for Innovative Medicine at Karolinska Institutet, Region Stockholm, SRP Diabetes Karolinska Institutet, StratRegen Karolinska Institutet and Karolinska Institutet. The authors apologize to those colleagues whose work has not been cited owing to space constraints.

The authors contributed equally to all aspects of the article.

The authors declare no competing interests.

Nature Reviews Immunology thanks C. Biron and the other, anonymous, reviewers for their contribution to the peer review of this work.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.